Article
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
Archives of neurology - 1 Aug 2004
Goldman Jennifer G, Goetz Christopher G, Berry-Kravis Elizabeth, Leurgans Sue, Zhou Lili
Abstract excerpt
BACKGROUND: Hallucinations in patients with Parkinson disease (PD), occurring in about one third of those receiving long-term dopaminergic therapy, contribute to morbidity and mortality. In matched Chinese PD subjects with and without hallucinations, the presence of the -45 C/T locus in the chole...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
